vs
Side-by-side financial comparison of James River Group Holdings, Inc. (JRVR) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
James River Group Holdings, Inc. is the larger business by last-quarter revenue ($167.7M vs $151.7M, roughly 1.1× Nutex Health, Inc.). James River Group Holdings, Inc. runs the higher net margin — 19.1% vs 7.8%, a 11.3% gap on every dollar of revenue. On growth, James River Group Holdings, Inc. posted the faster year-over-year revenue change (32.4% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-23.6M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -8.7%).
James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
JRVR vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $167.7M | $151.7M |
| Net Profit | $32.1M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | 14.6% | 20.4% |
| Net Margin | 19.1% | 7.8% |
| Revenue YoY | 32.4% | -41.1% |
| Net Profit YoY | 149.5% | -80.8% |
| EPS (diluted) | $0.59 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $167.7M | $151.7M | ||
| Q3 25 | $172.7M | $267.8M | ||
| Q2 25 | $174.8M | $244.0M | ||
| Q1 25 | $172.3M | $211.8M | ||
| Q4 24 | $126.7M | $257.6M | ||
| Q3 24 | $191.5M | $78.8M | ||
| Q2 24 | $188.3M | $76.1M | ||
| Q1 24 | $201.1M | $67.5M |
| Q4 25 | $32.1M | $11.8M | ||
| Q3 25 | $1.0M | $55.4M | ||
| Q2 25 | $4.8M | $-17.7M | ||
| Q1 25 | $9.6M | $21.2M | ||
| Q4 24 | $-64.8M | $61.6M | ||
| Q3 24 | $-39.4M | $-8.8M | ||
| Q2 24 | $7.6M | $-364.0K | ||
| Q1 24 | $15.4M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | 14.6% | 20.4% | ||
| Q3 25 | 1.5% | 48.7% | ||
| Q2 25 | 4.2% | 13.8% | ||
| Q1 25 | 9.3% | 38.1% | ||
| Q4 24 | -57.0% | 44.4% | ||
| Q3 24 | -27.1% | 12.3% | ||
| Q2 24 | 10.7% | 7.0% | ||
| Q1 24 | 16.4% | 2.1% |
| Q4 25 | 19.1% | 7.8% | ||
| Q3 25 | 0.6% | 20.7% | ||
| Q2 25 | 2.7% | -7.3% | ||
| Q1 25 | 5.6% | 10.0% | ||
| Q4 24 | -51.1% | 23.9% | ||
| Q3 24 | -20.6% | -11.2% | ||
| Q2 24 | 4.0% | -0.5% | ||
| Q1 24 | 7.7% | -0.5% |
| Q4 25 | $0.59 | $2.34 | ||
| Q3 25 | $-0.02 | $7.76 | ||
| Q2 25 | $0.06 | $-2.95 | ||
| Q1 25 | $0.16 | $3.33 | ||
| Q4 24 | $-2.44 | $11.56 | ||
| Q3 24 | $-1.10 | $-1.72 | ||
| Q2 24 | $0.13 | $-0.07 | ||
| Q1 24 | $0.35 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $260.9M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $538.2M | $329.4M |
| Total Assets | $4.9B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $260.9M | $185.6M | ||
| Q3 25 | $238.8M | $166.0M | ||
| Q2 25 | $220.0M | $96.7M | ||
| Q1 25 | $279.4M | $84.7M | ||
| Q4 24 | $362.3M | $40.6M | ||
| Q3 24 | $359.8M | $46.9M | ||
| Q2 24 | $672.5M | $40.8M | ||
| Q1 24 | $305.5M | $30.0M |
| Q4 25 | $538.2M | $329.4M | ||
| Q3 25 | $503.6M | $317.2M | ||
| Q2 25 | $492.6M | $235.3M | ||
| Q1 25 | $484.5M | $176.9M | ||
| Q4 24 | $460.9M | $132.4M | ||
| Q3 24 | $530.3M | $60.4M | ||
| Q2 24 | $541.8M | $62.7M | ||
| Q1 24 | $539.5M | $63.0M |
| Q4 25 | $4.9B | $918.5M | ||
| Q3 25 | $5.0B | $964.5M | ||
| Q2 25 | $5.0B | $841.0M | ||
| Q1 25 | $4.9B | $761.9M | ||
| Q4 24 | $5.0B | $655.3M | ||
| Q3 24 | $5.0B | $438.5M | ||
| Q2 24 | $4.7B | $422.4M | ||
| Q1 24 | $5.3B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.8M | $70.4M |
| Free Cash FlowOCF − Capex | $-23.6M | $69.0M |
| FCF MarginFCF / Revenue | -14.1% | 45.5% |
| Capex IntensityCapex / Revenue | 2.9% | 0.9% |
| Cash ConversionOCF / Net Profit | -0.59× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $-17.9M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.8M | $70.4M | ||
| Q3 25 | $34.3M | $99.5M | ||
| Q2 25 | $25.2M | $27.3M | ||
| Q1 25 | $-51.5M | $51.0M | ||
| Q4 24 | $-247.1M | $54.0K | ||
| Q3 24 | $-269.9M | $6.8M | ||
| Q2 24 | $-8.7M | $13.3M | ||
| Q1 24 | $24.1M | $3.1M |
| Q4 25 | $-23.6M | $69.0M | ||
| Q3 25 | $33.7M | $99.2M | ||
| Q2 25 | $24.7M | $26.5M | ||
| Q1 25 | $-52.7M | $50.9M | ||
| Q4 24 | $-252.0M | $-341.0K | ||
| Q3 24 | $-270.8M | $6.2M | ||
| Q2 24 | $-9.3M | $12.7M | ||
| Q1 24 | $23.3M | $2.3M |
| Q4 25 | -14.1% | 45.5% | ||
| Q3 25 | 19.5% | 37.0% | ||
| Q2 25 | 14.1% | 10.9% | ||
| Q1 25 | -30.6% | 24.0% | ||
| Q4 24 | -198.9% | -0.1% | ||
| Q3 24 | -141.4% | 7.8% | ||
| Q2 24 | -4.9% | 16.7% | ||
| Q1 24 | 11.6% | 3.4% |
| Q4 25 | 2.9% | 0.9% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.7% | 0.0% | ||
| Q4 24 | 3.9% | 0.2% | ||
| Q3 24 | 0.4% | 0.8% | ||
| Q2 24 | 0.3% | 0.7% | ||
| Q1 24 | 0.4% | 1.1% |
| Q4 25 | -0.59× | 5.95× | ||
| Q3 25 | 33.61× | 1.80× | ||
| Q2 25 | 5.29× | — | ||
| Q1 25 | -5.38× | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.14× | — | ||
| Q1 24 | 1.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JRVR
| Excess And Surplus Lines | $156.7M | 93% |
| Specialty Admitted Insurance | $10.9M | 7% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
